Allied Corp has successfully completed an international shipment of 180 kilograms of medical cannabis from Colombia, equally split between THC and CBD. The cargo has now cleared customs, demonstrating Allied's ability to execute on substantial volume orders into highly regulated markets and establishing a proven route for future transactions.
This shipment satisfies a purchase order signed in March of this year with an EU-GMP manufacturer with leading telehealth and pharmaceutical distribution capabilities. The order is part of a Master Agreement, which includes quarterly meetings to establish and fulfill ongoing supply requirements. Additionally, the manufacturer has already received permits for further imports of THC and CBD flower from Allied, paving the way for a future order.
"We are proud to announce this successful delivery and our partner's additional import permits, which showcases the strength of the partnership and aligns with our strategy to secure long-term, multi-year global partnerships", said Juba Hadid, VP of Global Sales. "This comes at an exciting time for the industry where we are seeing growing global adoption of medical cannabis, partly driven by the recent decriminalization in Germany and discussions of US rescheduling."
This successful delivery follows two shipments to Australia in Q4 last year and underscores the company's continued momentum, including its recent shipment to Europe and its recently signed 3-year 3-party flower distribution agreement to the UK.
For more information:
Allied Corp
allied.health